These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
||
|
þ
|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
|
|
Delaware
|
11-3363609
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
þ
|
|||
|
(Do not check if a smaller reporting company)
|
|
Part I — Financial Information
|
2
|
|||
|
Item 1.
|
Financial Statements:
|
2
|
||
|
Consolidated Balance Sheets
|
2
|
|||
|
Consolidated Statements of Income
|
3
|
|||
|
Consolidated Statements of Cash Flows
|
4
|
|||
|
Notes to Consolidated Financial Statements
|
5
|
|||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
12
|
||
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
14
|
||
|
Item 4T.
|
Controls and Procedures
|
14
|
||
|
Part II — Other Information
|
15
|
|||
|
Item 1.
|
Legal Proceedings
|
15
|
||
|
Item 1A.
|
Risk Factors
|
15
|
||
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
15
|
||
|
Item 3.
|
Defaults upon Senior Securities
|
15
|
||
|
Item 4.
|
Removed and Reserved
|
15
|
||
|
Item 5.
|
Other Information
|
15
|
||
|
Item 6.
|
Exhibits
|
15
|
||
|
EX-31.1
|
||||
|
EX-31.2
|
||||
|
EX-32.1
|
||||
|
EX-32.2
|
||||
|
IGAMBIT INC.
|
||||||||
|
CONSOLIDATED BALANCE SHEETS
|
||||||||
|
SEPTEMBER 30,
|
DECEMBER 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
ASSETS
|
||||||||
|
Current assets
|
||||||||
|
Cash
|
$ | 926,951 | $ | 857,074 | ||||
|
Accounts receivable
|
126,189 | 56,743 | ||||||
|
Prepaid expenses
|
330,122 | 8,838 | ||||||
|
Notes receivable - stockholders
|
17,000 | 17,000 | ||||||
|
Notes receivable
|
200,000 | -- | ||||||
|
Assets from discontinued operations
|
901,781 | 715,573 | ||||||
|
Total current assets
|
2,502,043 | 1,655,228 | ||||||
|
Property and equipment, net
|
4,159 | 895 | ||||||
|
Other assets
|
||||||||
|
Goodwill
|
111,026 | 111,026 | ||||||
|
Deposits
|
2,500 | 2,500 | ||||||
|
Assets from discontinued operations
|
-- | 150,985 | ||||||
|
Total other assets
|
113,526 | 264,511 | ||||||
| $ | 2,619,728 | $ | 1,920,634 | |||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable
|
$ | 389,636 | $ | 96,928 | ||||
|
Note payable - related party
|
26,886 | -- | ||||||
|
Loans payable - stockholders
|
2,504 | 2,504 | ||||||
|
Total current liabilities
|
419,026 | 99,432 | ||||||
|
Stockholders' equity
|
||||||||
|
Common stock, $.001 par value; authorized -
|
||||||||
|
75,000,000 shares; issued and outstanding -
|
||||||||
|
23,954,056 shares
|
23,954 | 23,954 | ||||||
|
Additional paid-in capital
|
2,531,513 | 2,448,413 | ||||||
|
Accumulated deficit
|
(354,765 | ) | (651,165 | ) | ||||
|
Total stockholders' equity
|
2,200,702 | 1,821,202 | ||||||
| $ | 2,619,728 | $ | 1,920,634 | |||||
|
IGAMBIT INC.
|
||||||||||||||||
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||
|
THREE MONTHS
|
NINE MONTHS
|
|||||||||||||||
|
ENDED
|
ENDED
|
|||||||||||||||
|
SEPTEMBER 30,
|
SEPTEMBER 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Sales
|
$ | 232,343 | $ | -- | $ | 646,002 | $ | -- | ||||||||
|
Cost of sales
|
99,387 | -- | 243,712 | -- | ||||||||||||
|
Gross profit
|
132,956 | -- | 402,290 | -- | ||||||||||||
|
Operating expenses
|
||||||||||||||||
|
General and administrative expenses
|
476,649 | 157,453 | 1,384,889 | 297,272 | ||||||||||||
|
Loss from operations
|
(343,693 | ) | (157,453 | ) | (982,599 | ) | (297,272 | ) | ||||||||
|
Other income
|
||||||||||||||||
|
Miscellaneous income
|
-- | 4,160 | -- | 4,160 | ||||||||||||
|
Interest income
|
1,853 | 867 | 2,771 | 3,275 | ||||||||||||
|
Total other income
|
1,853 | 5,027 | 2,771 | 7,435 | ||||||||||||
|
Loss from continuing operations before income tax benefit
|
(341,840 | ) | (152,426 | ) | (979,828 | ) | (289,837 | ) | ||||||||
|
Income tax expense (benefit)
|
(116,984 | ) | (52,782 | ) | (346,049 | ) | (107,059 | ) | ||||||||
|
Loss from continuing operations
|
(224,856 | ) | (99,644 | ) | (633,779 | ) | (182,778 | ) | ||||||||
|
Discontinued operations
|
||||||||||||||||
|
Income from discontinued operations
|
330,199 | 461,882 | 1,537,486 | 1,231,361 | ||||||||||||
|
Provision for income taxes
|
120,467 | 211,301 | 607,307 | 486,388 | ||||||||||||
|
Income from discontinued operations, net of taxes
|
209,732 | 250,581 | 930,179 | 744,973 | ||||||||||||
|
Net income (loss)
|
$ | (15,124 | ) | $ | 150,937 | $ | 296,400 | $ | 562,195 | |||||||
|
Basic and fully diluted earnings (loss) per common share:
|
||||||||||||||||
|
Continuing operations
|
$ | (.01 | ) | $ | (.00 | ) | $ | (.03 | ) | $ | (.01 | ) | ||||
|
Discontinued operations, net of tax
|
$ | .01 | $ | .01 | $ | .04 | $ | .03 | ||||||||
|
Net earnings per common share
|
$ | .00 | $ | .01 | $ | .01 | $ | .02 | ||||||||
|
Weighted average common shares outstanding
|
23,954,056 | 23,134,491 | 23,954,056 | 22,859,056 | ||||||||||||
|
IGAMBIT INC.
|
||||||||
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
||||||||
|
NINE MONTHS ENDED SEPTEMBER 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net income
|
$ | 296,400 | $ | 562,195 | ||||
|
Adjustments to reconcile net income to net
|
||||||||
|
cash (used) provided by operating activities
|
||||||||
|
Income from discontinued operations
|
(930,179 | ) | (744,973 | ) | ||||
|
Depreciation
|
894 | 447 | ||||||
|
Stock-based compensation expense
|
83,100 | 7,500 | ||||||
|
Increase (Decrease) in cash flows as a result of
|
||||||||
|
changes in asset and liability account balances:
|
||||||||
|
Accounts receivable
|
(69,446 | ) | -- | |||||
|
Prepaid expenses
|
(321,284 | ) | (1,703 | ) | ||||
|
Accounts payable
|
292,708 | (2,633 | ) | |||||
|
Net cash used by continuing operating activities
|
(647,807 | ) | (179,167 | ) | ||||
|
Net cash (used) provided by discontinued operating activities
|
(186,208 | ) | 418,436 | |||||
|
NET CASH (USED) PROVIDED BY OPERATING ACTIVITIES
|
(834,015 | ) | 239,269 | |||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Purchases of property and equipment
|
(4,158 | ) | -- | |||||
|
Increase in notes receivable
|
(200,000 | ) | -- | |||||
|
Increase in deposits
|
-- | (2,600 | ) | |||||
|
Payments received from loans to stockholders
|
-- | 198,281 | ||||||
|
Net cash (used) provided by continuing investing activities
|
(204,158 | ) | 195,681 | |||||
|
Net cash provided by discontinued investing activities
|
1,081,164 | 15,118 | ||||||
|
NET CASH PROVIDED BY INVESTING ACTIVITIES
|
877,006 | 210,799 | ||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Increase in loans payable to related party
|
26,886 | -- | ||||||
|
Net cash provided by continuing financing activities
|
26,886 | -- | ||||||
|
Net cash provided by discontinued financing activities
|
-- | -- | ||||||
|
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
26,886 | -- | ||||||
|
NET INCREASE IN CASH
|
69,877 | 450,068 | ||||||
|
CASH - BEGINNING OF PERIOD
|
857,074 | 322,439 | ||||||
|
CASH - END OF PERIOD
|
$ | 926,951 | $ | 772,507 | ||||
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
|
||||||||
|
Cash paid during the period for:
|
||||||||
|
Interest
|
$ | 851 | $ | 1,189 | ||||
|
Income taxes
|
390,634 | 4,698 | ||||||
|
Non-cash investing and financing activities:
|
||||||||
|
Cashless exercise of common stock options
|
$ | -- | $ | 7,500 | ||||
|
Stock-based compensation expense
|
83,100 | 7,500 | ||||||
| Cash | $ | 4,023 | ||
| Accounts receivable | 66,958 | |||
| Fixed assets | 2,993 | |||
| $ | 73,974 |
|
Nine months ended September 30, 2009:
|
||||||||||||
|
Pro Forma Balance Sheets
|
||||||||||||
|
iGambit
|
Jekyll
|
Combined
|
||||||||||
|
Current assets
|
$ | 1,371,447 | $ | 70,981 | $ | 1,442,428 | ||||||
|
Fixed assets
|
1,044 | 2,993 | 4,037 | |||||||||
|
Other assets
|
153,209 | 153,209 | ||||||||||
|
Total assets
|
1,525,700 | 73,974 | 1,599,674 | |||||||||
|
Current liabilities
|
2,121 | -- | 2,121 | |||||||||
|
Long-term liabilities
|
-- | -- | -- | |||||||||
|
Total liabilities
|
2,121 | -- | 2,121 | |||||||||
|
Stockholders' equity
|
1,523,579 | 73,974 | 1,597,553 | |||||||||
|
Total liabilities and stockholders' equity
|
$ | 1,525,700 | $ | 73,974 | $ | 1,599,674 | ||||||
|
Pro Forma Statements of Operations
|
||||||||||||
|
iGambit
|
Jekyll
|
Combined
|
||||||||||
|
Revenue
|
$ | -- | $ | 249,925 | $ | 249,925 | ||||||
|
Cost of sales
|
-- | 43,151 | 43,151 | |||||||||
|
Gross profit
|
-- | 206,774 | 206,774 | |||||||||
|
General and administrative expenses
|
418,772 | 208,965 | 627,737 | |||||||||
|
Loss from operations
|
(418,772 | ) | (2,191 | ) | (420,963 | ) | ||||||
|
Other income
|
7,435 | -- | 7,435 | |||||||||
|
Income tax benefit
|
107,059 | -- | 107,059 | |||||||||
|
Loss from continuing operations
|
(304,278 | ) | (2,191 | ) | (306,469 | ) | ||||||
|
Income from discontinued operations
|
744,973 | -- | 744,973 | |||||||||
|
Net income (loss)
|
$ | 440,695 | $ | (2,191 | ) | $ | 438,504 | |||||
|
Year ended December 31, 2008:
|
||||||||||||
|
Pro Forma Balance Sheets
|
||||||||||||
|
iGambit
|
Jekyll
|
Combined
|
||||||||||
|
Current assets
|
$ | 985,927 | $ | 80,650 | $ | 1,066,577 | ||||||
|
Fixed assets
|
1,491 | -- | 1,491 | |||||||||
|
Other assets
|
462,758 | -- | 462,758 | |||||||||
|
Total assets
|
1,450,176 | 80,650 | 1,530,826 | |||||||||
|
Current liabilities
|
4,754 | 3,929 | 8,683 | |||||||||
|
Long-term liabilities
|
491,538 | -- | 491,538 | |||||||||
|
Total liabilities
|
496,292 | 3,929 | 500,221 | |||||||||
|
Stockholders' equity
|
953,884 | 76,721 | 1,030,605 | |||||||||
|
Total liabilities and stockholders' equity
|
$ | 1,450,176 | $ | 80,650 | $ | 1,530,826 | ||||||
|
Pro Forma Statements of Operations
|
||||||||||||
|
iGambit
|
Jekyll
|
Combined
|
||||||||||
|
Revenue
|
$ | -- | $ | 359,590 | $ | 359,590 | ||||||
|
Cost of sales
|
-- | 62,100 | 62,100 | |||||||||
|
Gross profit
|
-- | 297,490 | 297,490 | |||||||||
|
General and administrative expenses
|
123,689 | 280,198 | 403,887 | |||||||||
|
(Loss) income from operations
|
(123,689 | ) | 17,292 | (106,397 | ) | |||||||
|
Other income
|
2,554 | -- | 2,554 | |||||||||
|
Income tax benefit
|
44,065 | -- | 44,065 | |||||||||
|
(Loss) income from continuing operations
|
(77,070 | ) | 17,292 | (59,778 | ) | |||||||
|
Income from discontinued operations
|
553,363 | -- | 553,363 | |||||||||
|
Net income
|
$ | 476,293 | $ | 17,292 | $ | 493,585 | ||||||
|
Year ended December 31, 2009:
|
||||||||||||
|
Pro Forma Statements of Operations
|
||||||||||||
|
iGambit
|
Jekyll
|
Combined
|
||||||||||
|
Revenue
|
$ | 6,500 | $ | 416,586 | $ | 423,086 | ||||||
|
Cost of sales
|
-- | 90,608 | 90,608 | |||||||||
|
Gross profit
|
6,500 | 325,978 | 332,478 | |||||||||
|
General and administrative expenses
|
617,505 | 453,123 | 1,070,628 | |||||||||
|
Loss from operations
|
(611,005 | ) | (127,145 | ) | (738,150 | ) | ||||||
|
Other income
|
3,908 | -- | 3,908 | |||||||||
|
Income tax benefit
|
238,334 | -- | 238,334 | |||||||||
|
Loss from continuing operations
|
(368,763 | ) | (127,145 | ) | (495,908 | ) | ||||||
|
Income from discontinued operations
|
1,047,035 | -- | 1,047,035 | |||||||||
|
Net income (loss)
|
$ | 678,272 | $ | (127,145 | ) | $ | 551,127 | |||||
|
2009
|
2008
|
|||||||
|
ASSETS
|
||||||||
|
Current:
|
||||||||
|
Accounts receivable
|
$
|
713,732
|
$
|
367,430
|
||||
|
Deferred income taxes
|
--
|
279,058
|
||||||
|
Noncurrent:
|
||||||||
|
Restricted cash
|
150,985
|
165,727
|
||||||
|
Deferred income taxes
|
--
|
98,750
|
||||||
|
Assets of discontinued operations
|
$
|
864,717
|
$
|
910,965
|
||||
|
LIABILITIES
|
||||||||
|
Noncurrent:
|
||||||||
|
Prepaid contingency
|
$
|
--
|
$
|
141,538
|
||||
|
Deferred compensation
|
--
|
350,000
|
||||||
|
Liabilities of discontinued operations
|
$
|
--
|
$
|
491,538
|
||||
|
Nine Months Ended
September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
StocS Stock options
|
2,468,900
|
296,900
|
||||||
|
Aver Common stock warrants
|
3,085,000
|
3,085,000
|
||||||
|
Basic Total shares excluded from calculation
|
5,553,900
|
3,381,900
|
||||||
|
Weighted
|
||||||||
|
Average
|
||||||||
|
Weighted
|
Remaining
|
|||||||
|
Average
|
Average
|
Contractual
|
||||||
|
Warrants
|
Exercise Price
|
Grant-Date
Fair Value
|
Life
(Years)
|
|||||
|
Warrants outstanding at January 1, 2010
|
3,085,000
|
$
|
0.83
|
$
|
0.10
|
|||
|
No warrant activity
|
--
|
--
|
--
|
|||||
|
Warrants outstanding at September 30, 2010
|
3,085,000
|
$
|
0.83
|
$
|
0.10
|
2.58
|
||
|
Weighted
|
||||||||
|
Average
|
||||||||
|
Weighted
|
Remaining
|
|||||||
|
Average
|
Average
|
Contractual
|
||||||
|
Options
|
Exercise Price
|
Grant-Date
Fair Value
|
Life
(Years)
|
|||||
|
Options outstanding at January 1, 2010
|
1,796,000
|
$
|
0.01
|
$
|
0.10
|
|||
|
Granted during 2010
|
672,000
|
0.10
|
0.10
|
|||||
|
Options outstanding at September 30, 2010
|
2,468,900
|
$
|
0.03
|
$
|
0.10
|
7.10
|
||
|
Nine months ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Weighted average risk-free rate
|
4.87
|
%
|
4.23
|
%
|
||||
|
Average expected life in years
|
5.0
|
5.1
|
||||||
|
Expected dividends
|
None
|
None
|
||||||
|
Volatility
|
20
|
%
|
20
|
%
|
||||
|
Forfeiture rate
|
0
|
%
|
0
|
%
|
||||
| 2010 | 2009 | |||||||
| From operations: | ||||||||
| Continuing operations: | ||||||||
| Current tax expense (benefit): | ||||||||
| Federal | $ | (275,153 | ) | $ | (85,764 | ) | ||
| State and local | (73,198 | ) | (21,295 | ) | ||||
| (348,351 | ) | (107,059 | ) | |||||
| Deferred tax expense (benefit) | ___ -- | -- | ||||||
| Total from continuing operations | (348,351 ) | (107,059) | ||||||
| Discontinued operations: | ||||||||
| Current tax expense (benefit) | ||||||||
| Federal | 479,696 | 384,185 | ||||||
| State and local | 127,611 | 102,203 | ||||||
| 607,307 | 486,388 | |||||||
| Deferred tax expense (benefit): | ||||||||
| Federal | -- | -- | ||||||
| State and local | -- | -- | ||||||
| -- | -- | |||||||
| Total from discontinued operations | 607,307 | 486,388 | ||||||
| Total | $ | 258,956 | $ | 379,329 | ||||
| Nine Months Ended | ||||||||
| September 30, | ||||||||
| 2010 | 2009 | |||||||
| Statutory tax rate | 34.0 | % | 34.0 | % | ||||
| Effect of: | ||||||||
| State income taxes, net of | ||||||||
| Federal income tax benefit | 5.5 | % | 5.5 | % | ||||
| Tax effect of expenses that are not | ||||||||
| deductible for income tax purposes | (4.2 | )% | (2.6 | )% | ||||
| Effective tax rate | 35.3 | % | 36.9 | % | ||||
| 2010 | 2009 | |||||||
| Current: | ||||||||
| Net operating loss carryforwards | $ | -- | $ | 279,058 | ||||
| Non-current: | ||||||||
| Net operating loss carryforwards | -- | -- | ||||||
| Deferred compensation | -- | 98,750 | ||||||
| $ | -- | $ | 377,808 | |||||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
Item 1.
|
Legal Proceedings.
|
|
Item 1A.
|
Risk Factors.
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
|
Item 3.
|
Defaults upon Senior Securities.
|
|
Item 4.
|
Removed and Reserved.
|
|
|
Item 5.
|
Other Information.
|
|
Item 6.
|
Exhibits
|
|||||
|
Exhibit No.
|
Description
|
|||||
|
31.1
|
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|||||
|
31.2
|
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|||||
|
32.1
|
Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
|
|||||
|
32.2
|
Certification of the Interim Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
|
|||||
|
iGambit, Inc.
|
||||
|
/s/ John Salerno
|
||||
|
John Salerno
|
||||
|
Chief Executive Officer
|
||||
|
/s/ Elisa Luqman
|
||||
|
Elisa Luqman
|
||||
|
Chief Financial Officer
|
||||
|
Exhibit No.
|
Description
|
||
|
31.1
|
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
31.2
|
Certification of the Interim Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
32.1
|
Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
|
||
|
32.2
|
Certification of the Interim Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|